Cargando…

Cellular and Humoral Responses Follow-up for 8 Months after Vaccination with mRNA-Based Anti-SARS-CoV-2 Vaccines

Vaccination against SARS-CoV-2 has become the main method of reducing mortality and severity of COVID-19. This work aims to study the evolution of the cellular and humoral responses conferred by two mRNA vaccines after two doses against SARS-CoV-2. On days 30 and 240 after the second dose of both va...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gil-Manso, Sergio, Carbonell, Diego, Pérez-Fernández, Verónica Astrid, López-Esteban, Rocío, Alonso, Roberto, Muñoz, Patricia, Ochando, Jordi, Sánchez-Arcilla, Ignacio, Bellón, Jose M, Correa-Rocha, Rafael, Pion, Marjorie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312914/ https://www.ncbi.nlm.nih.gov/pubmed/35884980 http://dx.doi.org/10.3390/biomedicines10071676

Ejemplares similares

IgG anti-RBD levels during 8-month follow-up post-vaccination with BNT162b2 and mRNA-1273 vaccines in healthcare workers: A one-center study
por: Gil-Manso, Sergio, et al.
Publicado: (2022)

Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days
por: Gil-Manso, Sergio, et al.
Publicado: (2021)

Comprehensive Flow Cytometry Profiling of the Immune System in COVID-19 Convalescent Individuals
por: Gil-Manso, Sergio, et al.
Publicado: (2022)

ABO blood group is involved in the quality of the specific immune response anti-SARS-CoV-2
por: Gil-Manso, Sergio, et al.
Publicado: (2021)

Ectopic FOXP3 Expression in Combination with TGF-β1 and IL-2 Stimulation Generates Limited Suppressive Function in Human Primary Activated Thymocytes Ex Vivo
por: Gallego-Valle, Jorge, et al.
Publicado: (2021)

Generation of Human Breg-Like Phenotype with Regulatory Function In Vitro with Bacteria-Derived Oligodeoxynucleotides
por: Gallego-Valle, Jorge, et al.
Publicado: (2018)

Waning Humoral Response 6 Month after Double Vaccination with the mRNA-BNT162b2 Vaccine in Hemodialysis Patients
por: Balčiuvienė, Vilma, et al.
Publicado: (2023)

Study of humoral and cellular immunity in vaccinated with mRNA‐1273
por: Gutiérrez‐Bautista, Juan Francisco, et al.
Publicado: (2022)

Humoral Response to SARS-CoV-2 mRNA Vaccine in Heart Transplant Recipients up to 4 Months After the Third Vaccine Injection
por: Ferré, V.M., et al.
Publicado: (2022)

Multidimensional analysis of immune cells from COVID-19 patients identified cell subsets associated with the severity at hospital admission
por: Gil-Manso, Sergio, et al.
Publicado: (2023)

Waning Humoral Response 3 to 6 Months after Vaccination with the SARS-COV-2 BNT162b2 mRNA Vaccine in Dialysis Patients
por: Berar-Yanay, Noa, et al.
Publicado: (2021)

Humoral Immune Response in IBD Patients Three and Six Months after Vaccination with the SARS-CoV-2 mRNA Vaccines mRNA-1273 and BNT162b2
por: Vollenberg, Richard, et al.
Publicado: (2022)

Humoral response to mRNA vaccines against SARS-CoV-2 in patients with humoral immunodeficiency disease
por: Bitzenhofer, Michaela, et al.
Publicado: (2022)

Comparison of Post-Vaccination Response between mRNA and Vector Vaccines against SARS-CoV-2 in Terms of Humoral Response after Six Months of Observation
por: Slomka, Sebastian, et al.
Publicado: (2023)

Humoral response to a fourth dose of mRNA vaccine in kidney transplant recipient responders to three doses of mRNA vaccine
por: de Nattes, Tristan, et al.
Publicado: (2022)

Blunted humoral response after mRNA vaccine in patients with haematological malignancies
por: Kamboj, Mini
Publicado: (2021)

Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimod
por: Capuano, Rocco, et al.
Publicado: (2022)

Humoral and cellular immune response to mRNA SARS-CoV-2 BNT162b2 vaccine in adolescents with rheumatic diseases
por: Udaondo, Clara, et al.
Publicado: (2022)

Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial
por: El Sahly, Hana M, et al.
Publicado: (2022)

The Presence of a Marked Imbalance Between Regulatory T Cells and Effector T Cells Reveals That Tolerance Mechanisms Could Be Compromised in Heart Transplant Children
por: Bernaldo-de-Quirós, Esther, et al.
Publicado: (2021)

Maintenance of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients after 1273-mRNA SARS-CoV-2 Vaccination
por: Gonzalez-Perez, Maria, et al.
Publicado: (2023)

Six-month humoral response to BNT162b2 mRNA COVID-19 vaccine in people with multiple sclerosis treated with natalizumab
por: Altieri, Manuela, et al.
Publicado: (2022)

Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection
por: Kang, Chang Kyung, et al.
Publicado: (2022)

Three-month analysis of total humoral response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers
por: Salvagno, Gian Luca, et al.
Publicado: (2021)

Humoral Response to mRNA-1273 SARS-CoV-2 Vaccine in Peritoneal Dialysis Patients: Is Boostering After Six Months Adequate?
por: Beilhack, Georg, et al.
Publicado: (2022)

Humoral immune response to COVID-19 mRNA vaccination in relation to selenium status
por: Demircan, Kamil, et al.
Publicado: (2022)

Humoral response to mRNA‐based COVID‐19 vaccine in patients with myeloid malignancies
por: Mori, Akio, et al.
Publicado: (2022)

The humoral response of mRNA COVID-19 vaccine in hematological diseases: The HEMVACO study
por: Gueguen, M., et al.
Publicado: (2022)

Humoral response to mRNA‐based COVID‐19 vaccine in patients with immune thrombocytopenia
por: Mori, Akio, et al.
Publicado: (2022)

Functional Mechanisms of Treg in the Context of HIV Infection and the Janus Face of Immune Suppression
por: López-Abente, Jacobo, et al.
Publicado: (2016)

Corrigendum: Functional Mechanisms of Treg in the Context of HIV Infection and the Janus Face of Immune Suppression
por: López-Abente, Jacobo, et al.
Publicado: (2018)

Humoral and Cellular Response after mRNA Vaccination in Nursing Homes: Influence of Age and of History of COVID-19
por: San Román, Jesús, et al.
Publicado: (2022)

Waning humoral response 6 months after SARS-CoV-2 vaccination with the mRNA-BNT162b2 vaccine in hemodialysis patients: time for a boost
por: Davidovic, Tamara, et al.
Publicado: (2021)

Cellular and Humoral Responses in Dialysis Patients after Vaccination with the BNT162b2 or mRNA-1273 Vaccines
por: Mavrovouniotis, Ilias, et al.
Publicado: (2023)

Humoral and cellular immunity to SARS-COV-2 after vaccination with mRNA vaccines in PLWH with discordant immune response. Influence of the vaccine administered
por: López-Cortés, Luis F., et al.
Publicado: (2023)

Humoral response and neutralising capacity at 6 months post-vaccination against COVID-19 among institutionalised older adults in Argentina
por: Rodriguez, Pamela E., et al.
Publicado: (2022)

Humoral and Cellular Response Following Vaccination With the BNT162b2 mRNA COVID-19 Vaccine in Patients Affected by Primary Immunodeficiencies
por: Amodio, Donato, et al.
Publicado: (2021)

Humoral immune response to SARS-CoV-2 mRNA vaccines is associated with choice of vaccine and systemic adverse reactions
por: Klingel, Hanna, et al.
Publicado: (2023)

Humoral responses to SARS-CoV-2 mRNA vaccines: Role of past infection
por: Gray, Ashley N., et al.
Publicado: (2021)

Boosting Humoral Immunity from mRNA COVID-19 Vaccines in Kidney Transplant Recipients
por: Tylicki, Leszek, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2c4jffqpd8crje0da1pgr48h4m